DRUG RESISTANCE TUBERCULOSIS (DR-TB): AN EMERGING THREAT
DOI:
https://doi.org/10.52206/jsmc.2015.5.2.656-657Abstract
Tuberculosis (TB) is a chronic communicable
disease that ranks second as the leading cause of
death from a single infectious agent.The
mortality rate of TB has steadily decreased by
45% since 1990 as more aggressive and
comprehensive plans were adopted worldwide.
However, despite all the possible measures to
fight against TB, its global burden remains the
same. According to the World Health
Organization (WHO) report in 2014, TB
infected 9 million people with 1.5 million
deaths 1. As Effective programmatic directly
observed treatment DOTS resulted in a
significant high cure rate of drug sensitive TB,
drug resistant TB (DR-TB) has gained much
more importance worldwide.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2021 The authors retain the copyrights. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on their website), as it can lead to productive exchanges, as well as greater citation of published work.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
